Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
0.920
+0.030 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $5.13 million as of December 20, 2024. Its market cap has decreased by -73.32% in one year.
Market Cap
5.13M
Enterprise Value
555.81K
1-Year Change
-73.32%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $5.13M, a decrease of -97.33%. That is a compound annual growth rate of -60.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.13M | -80.25% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 5.43M |
| Syros Pharmaceuticals | 5.41M |
| Hoth Therapeutics | 5.32M |
| SunLink Health Systems | 5.28M |
| FOXO Technologies | 5.14M |
| Sintx Technologies | 4.91M |
| Bionomics | 4.88M |
| Clearmind Medicine | 4.83M |